FDA Inspection 1037953 — Hospira Worldwide, LLC
The FDA completed an inspection of Hospira Worldwide, LLC on Jan 9, 2018 in Pleasant Prairie, WI. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 9, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Pleasant Prairie, WI (United States)